[⁶⁸Ga]Ga-PSMA-HBED-CC PET/CT demonstrates to be superior to ceCT in detecting early treatment response in metastatic clear cell renal cell carcinoma

Eur J Nucl Med Mol Imaging. 2021 Sep;48(10):3337-3339. doi: 10.1007/s00259-021-05250-1. Epub 2021 Mar 22.

Authors

Priscilla Guglielmo¹, Donatello Gasparro², Maura Scarlattei³, Giorgio Baldari³, Stefano Bola³, Silvia Migliari³, Antonino Sammartano³, Umberto Maestroni⁴, Livia Ruffini³

Affiliations

¹ Nuclear Medicine Unit, Azienda Ospedaliero-Universitaria of Parma, Parma, Italy. [email protected].
² Oncology Division, Azienda Ospedaliero-Universitaria of Parma, Parma, Italy.
³ Nuclear Medicine Unit, Azienda Ospedaliero-Universitaria of Parma, Parma, Italy.
⁴ Urology Division, Azienda Ospedaliero-Universitaria of Parma, Parma, Italy.

PMID: 33754194
DOI: 10.1007/s00259-021-05250-1

No abstract available

MeSH terms

Carcinoma, Renal Cell* / diagnostic imaging
Carcinoma, Renal Cell* / therapy
Edetic Acid / analogs & derivatives
Gallium Radioisotopes
Humans
Male
Positron Emission Tomography Computed Tomography
Prostatic Neoplasms*
Radiopharmaceuticals

Substances

Gallium Radioisotopes
Radiopharmaceuticals
N,N'-bis(2-hydroxy-5-(ethylene-beta-carboxy)benzyl)ethylenediamine N,N'-diacetic acid
Edetic Acid